GLP-1 receptor agonist treatment in women with polycystic ovary syndrome—a systematic review and meta-analysis
European Journal of Endocrinology · 04.03.2026 · 194 (3) · S25-S39
DOI: 10.1093/ejendo/lvag033 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Endocrinology, online erschienen am 17.02.2026. Verfasst von Maria Forslund und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg SE-41345, Sweden. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish government, ALF-agreement.
Abstract (Originalsprache)
Objective
To assess the effect of treatment with glucagon-like peptide-1 receptor agonists (GLP1-RAs) on weight-related, metabolic, and reproductive outcomes and health economics in women with polycystic ovary syndrome (PCOS).
Design
Systematic review and meta-analysis, Prospero CRD42024535096 Methods Cochrane Library, EMBASE, and Medline were searched on September 20, 2024 for studies including women with PCOS, comparing GLP1-RAs with no treatment, placebo, lifestyle intervention, combined oral contraceptives, antiandrogenic drugs, or metformin in randomized controlled trials (RCTs).
Results
A total of 9654 studies were identified, 365 read in full text and 11 RCTs were included. GLP1-RAs as an add-on showed a reduction in BMI compared to the control group, mean difference (95% CI), −1.38 (−2.39 to −0.38) kg/m2 (low certainty). For LDL cholesterol and triglycerides, no difference was noted between the groups (low certainty), whereas evidence was insufficient to draw conclusion regarding glucose, insulin, hirsutism, and menstrual regularity. No studies were identified assessing quality of life, mental health, or cost-effectiveness outcomes.
Conclusion
GLP-1-RAs are associated with modest short-term weight loss in women with PCOS and overweight or obesity. Evidence for benefits on metabolic, reproductive, or psychological outcomes remains uncertain due to low-quality data, and no studies have evaluated cost-effectiveness.
Trial registration
The protocol for the systematic review was registered prospectively in Prospero, CRD42024535096.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg SE-41345, Sweden.
- Department of Gynecology and Reproduction, Sahlgrenska University Hospital, SE-41346 Gothenburg, Sweden.
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, SE-14183 Huddinge, Sweden.
- Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), SE-10233 Stockholm, Sweden.
- Department of Women's and Children's Health, Karolinska Institutet, SE-17176 Stockholm, Sweden.
- Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, SE-17176 Stockholm, Sweden.
ORCID-Profile: Maria Forslund
Förderung
- Swedish government
- ALF-agreement
Zitieren
APA
Forslund, M., Wändell, P., Forsberg, L., Österberg, M., Dagerhamn, J., Wernersson, E., Kärrman Fredriksson, M., Ringborg, A., & Lindén Hirschberg, A. (2026). GLP-1 receptor agonist treatment in women with polycystic ovary syndrome—a systematic review and meta-analysis. European Journal of Endocrinology, 194(3), S25-S39. https://doi.org/10.1093/ejendo/lvag033
Vancouver
Forslund M, Wändell P, Forsberg L, Österberg M, Dagerhamn J, Wernersson E, et al. GLP-1 receptor agonist treatment in women with polycystic ovary syndrome—a systematic review and meta-analysis. European Journal of Endocrinology. 2026;194(3):S25-S39. doi:10.1093/ejendo/lvag033
BibTeX
@article{Forslund2026,
author = {Forslund, Maria and Wändell, Per and Forsberg, Lisa and Österberg, Marie and Dagerhamn, Jessica and Wernersson, Emma and Kärrman Fredriksson, Maja and Ringborg, Anna and Lindén Hirschberg, Angelica},
title = {GLP-1 receptor agonist treatment in women with polycystic ovary syndrome—a systematic review and meta-analysis},
journal = {European Journal of Endocrinology},
year = {2026},
volume = {194},
number = {3},
pages = {S25--S39},
doi = {10.1093/ejendo/lvag033}
}
EUVIMED